VEGF: A modifier of the del122q11 (DiGeorge) syndrome?
Article Abstract:
Research findings in mouse, fish and human suggest that the vascular endothelial growth factor (VEGF) modifies cardiovascular birth defects in the hemizygous deletion of chromosome del22q11 syndrome. The DiGeorge syndrome comprises of life-threatening cardiovascular birth defects, including thymic, parathyroid, craniofacial origin, in infants.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Impaired myocardial angiogenesis and eschemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF(sub.164) and VEGF(sub.188)
Article Abstract:
In the absence of vascular endothelial growth factor genes, VEGF(sub.164) and VEGF(sub.188), in mice, impaired myocardial angiogenesis is seen as are reduced myocardial perfusion and fatal ischemic cardiomyopathy. The pursuit of gene therapy strategies of ischemic heart disease led researchers to generate the mice using targeted embryonic stem cells.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Fetal esophageal ligation induces expression of vascular endothelial growth factor messenger ribonucleic acid in fetal membranes
- Abstracts: Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: involvement of transforming growth factor beta1
- Abstracts: Intraoperative cholangiography and risk of common bile duct injury during cholecystectomy. Has Misdiagnosis of Appendicitis Decreased Over Time? A Population-Based Analysis
- Abstracts: Two - photon fluorescence correlation microscopy reveals the two - phase nature of transport in tumors. Recognition of tumor blood vessel normalization as a new antiangiogenic concept
- Abstracts: Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer